NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  225.15
+4.46 (2.02%)
AAPL  275.55
+4.06 (1.49%)
AMD  215.33
+11.55 (5.67%)
BAC  52.03
+0.47 (0.91%)
GOOG  317.23
+17.58 (5.87%)
META  614.32
+20.07 (3.38%)
MSFT  475.50
+3.38 (0.72%)
NVDA  182.64
+3.76 (2.10%)
ORCL  200.99
+2.23 (1.12%)
TSLA  419.25
+28.16 (7.20%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.